Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 49.14

From 52W high−26.66%

Volume3.69M

Market capCNY 40.44B

P/E (TTM)25.0x

P/S (TTM)8.4x

Div yield2.45%

Key dataSep 18, 2026

Open

CNY 49.14

From 52W high

−26.66%

Volume

3.69M

Market cap

CNY 40.44B

ValuationView details →

P/E (Fwd)

19.2x

EV/EBITDA

17.5x

P/E (TTM)

25.0x

RSI (14)

46.5

MomentumView details →

1D Return

−0.77%

YTD Return

−13.00%

ValuationView details →

P/E (Fwd)

19.2x

P/E (TTM)

25.0x

EV/EBITDA

17.5x

EV/Sales

8.1x

P/S (TTM)

8.4x

P/B (TTM)

4.5x

ProfitabilityView details →

Gross Margin

70.60%

Net Margin

35.47%

EBITDA Margin

46.12%

ROE (TTM)

17.13%

ROA (TTM)

15.90%

Asset Turnover

0.45x

GrowthView details →

Revenue YoY

−1.25%

EPS YoY

−11.69%

FCF YoY

+101.73%

Revenue CAGR 3Y

+14.52%

EPS CAGR 3Y

+6.84%

EBITDA YoY

—

MomentumView details →

1D Return

−0.77%

YTD Return

−13.00%

1Y Return

−28.09%

RSI (14)

46.5

vs 50D SMA

+0.00%

vs 200D SMA

−3.17%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

10.54x

Quick Ratio

8.64x

Div Yield

2.45%

Div Rate

CNY 1.20

Div Growth 1Y

−7.69%

EarningsView details →

EPS (Actual)

CNY 0.54

EPS Surprise

2.29%

Beats (12Q)

1/12

Next Q EPS Est

CNY 0.62

Avg Surprise (4Q)

2.29%

Rev Surprise

3.26%

Financials snapshotView financials →

Revenue (TTM)

4.58B

Net Income (TTM)

1.62B

Op. CF (TTM)

1.86B

Next earningsOct 22, 2026 →

Latest newsMore news →

Shenzhen New Industries Biomedical Engineering received a medical device registration certificate from China's National Medical Products Administration for its fully automated nucleic acid detection and analysis system (model Molecision R8).4d ago

Shenzhen New Industries Biomedical Engineering Co., Ltd. received a Class II Medical Device Registration Certificate from the Guangdong Provincial Drug Administration for its angiotensin-converting enzyme assay kit (FAPGG substrate method), valid from 2026-08-19 to 2031-08-18.27d ago

Similar companies

云南铜业000878.SZ 冰轮环境000811.SZ 多氟多002407.SZ 联特科技301205.SZ 联合动力301656.SZ 华润三九000999.SZ Find similar companies →

Latest newsMore news →

Shenzhen New Industries Biomedical Engineering received a medical device registration certificate from China's National Medical Products Administration for its fully automated nucleic acid detection and analysis system (model Molecision R8).4d ago Shenzhen New Industries Biomedical Engineering Co., Ltd. received a Class II Medical Device Registration Certificate from the Guangdong Provincial Drug Administration for its angiotensin-converting enzyme assay kit (FAPGG substrate method), valid from 2026-08-19 to 2031-08-18.27d ago